Homepage - Ophthalmology Advisor
WEBBy Alan P. Lyss, MD. Factors preventing more widespread use of biosimilars in oncology include the cost and complexity of biosimilar development, oncologists’ lack of knowledge about biosimilars, and the …
Photobiomodulation: An Emerging Dry AMD …
WEBMar 20, 2024 · Photobiomodulation (PBM) is an emerging therapy that has shown promising potential as a possible treatment for patients with nonexudative intermediate AMD. In truth, this low-level laser therapy …
FDA Alerts: Ophthalmology Drug and Device Approvals
WEBFeb 20, 2024 · Drug Regulatory Updates. Susvimo: Diabetic Eye Conditions. The FDA has accepted the application for Susvimo ® (ranibizumab injection, Genentech) to treat diabetic macular edema …
Restoring the Retina: Coming Advancements to Repair …
WEBFeb 16, 2021 · Retinal implants capture light and stimulate secondary neurons that have remained in the retina, such as ganglion cells and bipolar cells, which then send signals to the brain through the optic nerve. …
Ofatumumab vs Teriflunomide Is More Efficacious in Minority …
Patient Trust in Physicians, Hospitals Decreased During the COVID …
Trifocal EDOF Lens Implants Have Better Outcomes Than …
Updated LASIK Procedure Corrects Myopic Astigmatism
Think Medically About Macular Holes - Ophthalmology Advisor
Goniotomy, Phacoemulsification Provides 36-Month IOP …